Patents
Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
04/2007
04/10/2007US7202269 GlyT2 modulators
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007CA2262367C Anti-bacterial amine derivatives
04/10/2007CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
04/04/2007EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
04/04/2007CN1942428A CETP inhibitors
03/2007
03/29/2007WO2007034924A1 METALLO-β-LACTAMASE INHIBITOR
03/29/2007CA2620675A1 Metallo-.beta.-lactamase inhibitors
03/28/2007EP1765420A1 Sanitizing composition
03/28/2007CN1938244A Fluoridation method
03/28/2007CN1307151C Method for producing quaternary salt phenolate solutions and for regenerating and recycling quaternary salt phenolate solutions from reaction mixtures
03/21/2007EP1763513A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers
03/21/2007EP0865446B1 Agents for promoting bone formation
03/15/2007WO2007029587A1 β SECRETASE INHIBITOR
03/14/2007CN1304368C Improved technique for producing tetramethyl guanidine
03/07/2007CN1923803A Arginine rosmarinate, preparation method, pharmaceutical composition and use thereof
03/07/2007CN1303070C Compound possessing fungicidal property and its usage for preventing and treating plant disease
03/06/2007CA2168319C 4-mercaptobenzoylguanidine derivatives
03/06/2007CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
02/2007
02/28/2007EP1756041A2 Polycationic compounds and uses thereof
02/28/2007CN1922133A Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
02/28/2007CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii
02/27/2007US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
02/22/2007WO2007021839A2 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
02/22/2007CA2619005A1 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
02/21/2007EP1753733A1 Small molecules for treatment of hypercholesterolemia and related diseases
02/21/2007EP1254075B1 Nonaborate compositions and their preparation
02/14/2007CN1914168A Peptidyl arginine deiminase type IV inhibitor
02/07/2007EP1749522A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
02/06/2007US7173154 Transfection reagents
01/2007
01/30/2007US7169810 Phenylalkyleneoxybenzene derivatives; insulin resistance; diabetes, obesity, dyslipidemia treatment; hypotensive agents
01/24/2007CN1901881A Compositions and dosage forms for enhanced absorption
01/24/2007CN1901880A Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
01/24/2007CN1900056A Process for preparing ethyl creatine hydrochloride
01/23/2007US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
01/23/2007CA2182987C Novel phosphoric acid-amino acid complex salt and additive composition containing the salt and used in feed for ruminant mammals
01/17/2007CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament
01/03/2007EP1737811A1 Cetp inhibitors
01/02/2007US7157596 Inhibitors of serine protease activity of matriptase or MTSP1
12/2006
12/28/2006WO2006136846A1 Imaging 18f or 11c-labelled alkylthiophenyl guanidines
12/28/2006WO2006135978A1 Antiviral compounds and methods
12/28/2006CA2612403A1 Antiviral compounds and methods
12/28/2006CA2610744A1 Imaging 18f or 11c-labelled alkylthiophenyl guanidines
12/27/2006EP1736466A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
12/27/2006CN1886367A Fused ring dicationic anti-protozoan agents and their prodrugs
12/26/2006US7153869 Substituted amino acids as erythropoietin mimetics
12/20/2006EP1734064A2 Polymer guanidine derivatives as a cytostatic medicament
12/20/2006EP1732865A1 Fluoridation method
12/20/2006CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris
12/19/2006CA2251169C Quaternary cytofectins
12/14/2006US20060280796 carrier having guanidinium groups enhancing drug delivering across a biological membrane, nuclear membrane or blood-brain barrier into a cell; an ionic complex through ionic bonds between the carrier and the drug or diagnostic reagent
12/12/2006US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/06/2006EP1728784A1 Fluorene derivative
12/06/2006CN1875271A Treating neuropathic pain with neuropeptide FF receptor 2 agonists
12/05/2006US7145039 Transfection reagents
12/05/2006US7145037 Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
12/03/2006CA2547744A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
11/2006
11/30/2006US20060270710 Methods for inhibition of angiogenesis
11/29/2006EP1678110A4 Inositol-based molecular transporters and processes for the preparation thereof
11/29/2006CN1871205A Method for synthesis of acrylamide derivatives
11/29/2006CN1869009A Method of extracting carbamyl ornithine from watermelon rind
11/29/2006CN1286806C Process for preparing guanidine carbonate
11/23/2006US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/22/2006EP1724254A2 Novel compositions for the delivery of negatively charged molecules
11/22/2006EP1723946A1 Composition for straightening the hair comprising at least one multi-guanidine not being a hydroxide
11/14/2006CA2408191C Biocidal polymers based on guanidine salts
11/14/2006CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006WO2006118283A1 Novel guanidine compound, method for producing same, and bactericidal composition using same
11/09/2006US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
11/08/2006EP1718960A2 Carrier ampholytes of high ph range
11/08/2006CN1283621C Alkyl urea vitamin A protagonist I
11/07/2006CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/02/2006US20060247274 N,N-bis(3-Phenoxycinnamyl)Glu(O-t-Bu)-OMe; demonstrate competitive binding with the natural ligand; ease administration, cost less and facilitate patient compliance; USEFUL IN TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH ERYTHROPOIETIN RECEPTOR
11/02/2006US20060246104 Stable rgd peptidomimetic composition
11/02/2006EP1717224A1 Peptidyl arginine deiminase type iv inhibitor
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/26/2006WO2003006628A3 Nad synthetase inhibitors and uses thereof
10/26/2006DE4244539B4 Duale Inhibitoren der No-Synthese und Cyclooxygenase, Verfahren zu ihrer Herstellung und therapeutische Präparate, die sie enthalten Dual inhibitors of NO synthesis and cyclooxygenase, processes for their preparation and therapeutic compositions containing them
10/24/2006CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines
10/19/2006WO2006108643A2 Organic compounds
10/19/2006CA2601990A1 Organic compounds
10/18/2006EP1711458A1 Method for producing guanidinium salts
10/18/2006EP1711455A2 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
10/11/2006EP1504022B1 Process for the synthesis of peptide amides by side-chain attachment to a solid phase
10/11/2006CN1844093A Process for preparing metformin hydrochloride
10/04/2006EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006CN1842517A 芴衍生物 Fluorene derivatives
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006CA2234638C New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
10/03/2006CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/2006
09/28/2006WO2006051314A8 Guanidine derivatives as inhibitors of ddah
09/21/2006WO2006097015A1 Agmatines labeled by deuterium and tritium and their uses in biochemical and medicinal research
09/20/2006CN1834085A Trilerium and trilerium marked agmatine and application in biochemistry and medicine research
09/20/2006CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
09/19/2006US7109373 Creatine salts and method of making same
09/19/2006CA2140989C Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnosticagent, and a medicament containing them
09/14/2006WO2005105152A3 Lipids, lipid complexes and use thereof
09/13/2006CN1274712C Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof
09/13/2006CN1274670C Diaminopropionic acid derivatives
09/12/2006US7105501 Compositions with vascular damaging activity
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 54